HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Energized Skin-Care Gizmos Making Waves In 2012

This article was originally published in The Rose Sheet

Executive Summary

“Kinetique” or energy-based beauty, including anti-aging devices, will help define the global market in 2012, says research firm Mintel. With strong presence in U.S., aesthetic devices are gaining in popularity in EU.

You may also be interested in...



Skin Devices Poised To Tap “Wealth Of Unrealized Potential” – Kline

Pricing products more economically and expanding distribution are challenges for skin-care device marketers, but there is significant opportunity for firms that can reach consumers at the mass retail level, says Kline & Company. The market for home-use aesthetic devices grew globally by 22% in 2012.

Cosmeceutical Actives Span Price Points As Functional Product Demand Grows

Consumers wanting “visible results” increase demand for higher-end cosmeceutical actives once predominantly exclusive to luxury products. Actives like vitamins, collagen and plant stem cells now are appearing in more affordable product formulations.

Cosmeceutical Actives Span Price Points As Functional Product Demand Grows

Consumers wanting “visible results” increase demand for higher-end cosmeceutical actives once predominantly exclusive to luxury products. Actives like vitamins, collagen and plant stem cells now are appearing in more affordable product formulations.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018004

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel